Global private equity and venture capital news and research

Posts Tagged ‘life sciences’

14 September 2015

Avalon Ventures registers first capital for $300m-targeting Fund XI

dollar-163473_1280 Early-stage IT and life sciences investor Avalon Ventures is eyeing up to 300m for its latest fund.

1 September 2015

Montreux Equity Partners bags nearly $75m for Fund V

organic-679701_1280 Life science-focused venture capital firm Montreux Equity Partners has pulled in $74.4m for its fifth fund in what appears to be a final close.

21 April 2015

Australia’s Brandon Capital closes record life science-focused Fund III on $154.5m

santarus life sciences Venture capital firm Brandon Capital has closed its third life sciences venture capital fund on A$200m ($154.5m).

25 March 2015

Poland like Germany ’20 years ago’ says new VC fund manager $

poland flag A venture capital fund focused solely on Poland-related life sciences startups may sound niche, but general partner Kreske Nickelsen sees great potential in the burgeoning Polish tech industry.

24 March 2015

First Polish life sciences VC fund holds $42m first close

warsaw_lrg Venture investor Join Polish Investment Fund Management has announced the first close of its first fund after raising $42m.

20 March 2015

Index offloads cardiovascular-drug startup X01

blood-cells_sq Life sciences and IT investor Index Ventures has completed the sale of cardiovascular-drug startup X01, to Johnson & Johnson.

9 January 2015

Sofinnova Ventures hires biotech veteran Welch as executive partner

Dan W_1420698769 Life sciences investor Sofinnova Ventures has hired former biotech CEO Daniel Welch as executive partner.

29 December 2014

Domain Associates scores $163m in first fundraise since 2009

santarus life sciences Life sciences-focused Domain Associates has pulled in $163.6m for its ninth venture capital fund.

28 October 2014

Advent Venture Partners beats target in rapid second Life Sciences fund close

santarus life sciences Advent Venture Partners has beaten its target for its life science team’s second fundraise by holding a £145.5m final close for the vehicle after just weeks in the market.

7 October 2014

TVM Life Science bags more than $200m in Fund VII final close

news_spirogen_molecule_lrg Canada and Germany-based venture capital investor TVM Capital Life Science has beaten the target for its latest fund by closing on more than $200m.

Page 1 of 2212345...1020...Last »

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015